Attovia Therapeutics, Inc. (ATTO)
NASDAQ: ATTO · Real-Time Price · USD
17.82
+0.64 (3.76%)
Oct 5, 2026, 1:33 PM EDT - Market open
Attovia Therapeutics Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Attovia Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $42.2. The average 1-year stock price forecast is 136.88% higher than the current stock price, while the lowest is $30 (+68.40%) and the highest is $52 (+191.89%).
Price Target: $42.2 (+136.88%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Sep 4, 2026.
Analyst Ratings
The average analyst rating for Attovia Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $30 | Buy | Maintains | $30 | +68.40% | Sep 4, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $45 | Buy | Maintains | $45 | +152.60% | Sep 3, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $39 | Buy | Reiterates | $39 | +118.92% | Sep 3, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $45 | Buy | Maintains | $45 | +152.60% | Sep 3, 2026 |
Financial Forecast
Revenue This Year
n/a
from 1.35M
Decreased by -100.00%
Revenue Next Year
n/a
EPS This Year
-3.45
EPS Next Year
-2.38
from -3.45
EPS and Forward PE are based on non-GAAP adjusted numbers.